ATA1021774A - Verfahren zur herstellung von neuen pregnan-21-saeure-derivaten - Google Patents

Verfahren zur herstellung von neuen pregnan-21-saeure-derivaten

Info

Publication number
ATA1021774A
ATA1021774A AT1021774A AT1021774A ATA1021774A AT A1021774 A ATA1021774 A AT A1021774A AT 1021774 A AT1021774 A AT 1021774A AT 1021774 A AT1021774 A AT 1021774A AT A1021774 A ATA1021774 A AT A1021774A
Authority
AT
Austria
Prior art keywords
pregnan
acid derivatives
producing new
producing
new
Prior art date
Application number
AT1021774A
Other languages
English (en)
Other versions
AT347612B (de
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2365102A external-priority patent/DE2365102C2/de
Priority claimed from DE19742441284 external-priority patent/DE2441284C2/de
Priority claimed from DE19742444618 external-priority patent/DE2444618C2/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of ATA1021774A publication Critical patent/ATA1021774A/de
Application granted granted Critical
Publication of AT347612B publication Critical patent/AT347612B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0095Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 carbon in position 21 is part of carboxylic group

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT1021774A 1973-12-21 1974-12-20 Verfahren zur herstellung von neuen pregnan-21- saeure-derivaten AT347612B (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2365102A DE2365102C2 (de) 1973-12-21 1973-12-21 Neue Pregnansäure-Derivate
DE19742441284 DE2441284C2 (de) 1973-12-21 1974-08-27 Verfahren zur Herstellung von Pregnansäure-Derivaten
DE19742444618 DE2444618C2 (de) 1974-09-16 1974-09-16 Neue Pregnan-21-säure-Derivate

Publications (2)

Publication Number Publication Date
ATA1021774A true ATA1021774A (de) 1978-05-15
AT347612B AT347612B (de) 1979-01-10

Family

ID=27185702

Family Applications (2)

Application Number Title Priority Date Filing Date
AT1021774A AT347612B (de) 1973-12-21 1974-12-20 Verfahren zur herstellung von neuen pregnan-21- saeure-derivaten
AT398978A AT355744B (de) 1973-12-21 1978-06-01 Verfahren zur herstellung von neuen pregnan- 21-saeure-derivaten

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT398978A AT355744B (de) 1973-12-21 1978-06-01 Verfahren zur herstellung von neuen pregnan- 21-saeure-derivaten

Country Status (22)

Country Link
US (1) US3944577A (de)
JP (1) JPS5840559B2 (de)
AT (2) AT347612B (de)
AU (1) AU496759B2 (de)
BE (1) BE823682A (de)
CA (1) CA1060885A (de)
CH (1) CH612688A5 (de)
DD (1) DD119586A5 (de)
DK (1) DK139361C (de)
EG (1) EG11731A (de)
ES (1) ES433216A1 (de)
FI (1) FI53708C (de)
FR (1) FR2255079B1 (de)
GB (1) GB1497265A (de)
IE (1) IE40456B1 (de)
IL (1) IL46296A (de)
IT (1) IT1043908B (de)
NL (1) NL7416805A (de)
NO (1) NO744623L (de)
PH (1) PH11030A (de)
SE (1) SE410607B (de)
YU (1) YU338574A (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039668A (en) * 1973-06-23 1977-08-02 Schering Aktiengesellschaft Corticoid-containing inhalants
DK118776A (da) * 1975-03-21 1976-09-22 Schering Ag Pregnansyrederivater
US4181720A (en) * 1978-04-05 1980-01-01 Syntex (U.S.A.) Inc. Corticosteroid antiinflammatory agents
US4257969A (en) * 1980-01-23 1981-03-24 E. R. Squibb & Sons, Inc. 16,17-Dihydroxypregnene-21-carboxylic acids and derivatives
US4588530A (en) * 1982-07-30 1986-05-13 Florida Agricultural And Mechanical University Anti-inflammatory prednisolone steroids
US4511511A (en) * 1982-12-15 1985-04-16 Crozer-Chester Medical Center Prednisolone derivatives
US4897260A (en) * 1987-05-22 1990-01-30 The Rockefeller University Compositions that affect suppression of cutaneous delayed hypersensitivity and products including same
JP3176075B2 (ja) * 1991-03-04 2001-06-11 帝國製薬株式会社 新規なステロイド誘導体
MXPA04003266A (es) * 2001-10-05 2004-07-08 Combinatorx Inc Combinaciones para el tratamiento de desodrdenes inmuno-inflamatorios.
TW200517114A (en) * 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
CA2652773A1 (en) * 2006-05-22 2007-12-06 Combinatorx, Incorporated Methods and compositions for the treatment of diseases or conditions associated with increased c-reactive protein, interleukin-6, or interferon-gamma levels
CA2737131A1 (en) * 2007-09-19 2009-03-26 Zalicus Inc. Therapeutic regimens for the treatment of immunoinflammatory disorders
JP2011506607A (ja) * 2007-12-17 2011-03-03 ザリカス インコーポレイティッド 免疫炎症性障害の処置のための治療法
JP7330718B2 (ja) 2019-02-28 2023-08-22 三菱重工業株式会社 ガスタービンプラント、及びその排出二酸化炭素回収方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3833563A (en) * 1971-10-04 1974-09-03 Schering Ag Novel pregnanoic acid derivatives
US3828080A (en) * 1972-01-20 1974-08-06 Glaxo Lab Ltd Androstane-17beta-carboxylic acids and processes for the preparation thereof
DE2260303C2 (de) * 1972-12-06 1983-12-15 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von Pregnansäurederivaten

Also Published As

Publication number Publication date
IL46296A (en) 1978-10-31
CA1060885A (en) 1979-08-21
IE40456L (en) 1975-06-21
IL46296A0 (en) 1975-03-13
DK139361B (da) 1979-02-05
AT347612B (de) 1979-01-10
ES433216A1 (es) 1977-03-01
FI53708C (fi) 1978-07-10
DD119586A5 (de) 1976-05-05
FR2255079B1 (de) 1978-02-03
IT1043908B (it) 1980-02-29
FI53708B (de) 1978-03-31
NL7416805A (nl) 1975-06-24
BE823682A (fr) 1975-06-20
CH612688A5 (de) 1979-08-15
FR2255079A1 (de) 1975-07-18
DK139361C (da) 1979-07-09
AT355744B (de) 1980-03-25
PH11030A (en) 1977-10-25
YU338574A (en) 1982-05-31
JPS5840559B2 (ja) 1983-09-06
AU496759B2 (en) 1978-10-26
FI370774A7 (de) 1975-06-22
GB1497265A (en) 1978-01-05
NO744623L (de) 1975-07-21
IE40456B1 (en) 1979-06-06
SE7416038L (de) 1975-06-23
AU7658574A (en) 1976-06-24
SE410607B (sv) 1979-10-22
US3944577A (en) 1976-03-16
ATA398978A (de) 1979-08-15
DK667574A (de) 1975-09-08
EG11731A (en) 1977-11-30
JPS5095257A (de) 1975-07-29

Similar Documents

Publication Publication Date Title
AT335419B (de) Verfahren zur herstellung von neuen 2-cyclohexen-1-on-derivaten
AT347054B (de) Verfahren zur herstellung von neuen nonapeptidamid-derivaten
AT341119B (de) Verfahren zur herstellung von neuen prostanderivaten
AT347053B (de) Verfahren zur herstellung von neuen nonapeptidamid-derivaten
AT326137B (de) Verfahren zur herstellung von neuen 3-phenyl-6-halogen-pyridanzinverbindungen
ATA1021774A (de) Verfahren zur herstellung von neuen pregnan-21-saeure-derivaten
AT341689B (de) Verfahren zur herstellung von neuen octapeptiden
AT351180B (de) Verfahren zur herstellung von neuen d-homo- steroiden
AT331399B (de) Verfahren zur herstellung von neuen azetidinderivaten
AT335607B (de) Verfahren zur herstellung von neuen beta-lactamantibiotica
AT339913B (de) Verfahren zur herstellung von neuen diazin-derivaten
AT342583B (de) Verfahren zur herstellung von neuen carbazol-derivaten
AT339296B (de) Verfahren zur herstellung von neuen xanthenderivaten
AT338240B (de) Verfahren zur herstellung von neuen phenoxyathylaminen
AT333952B (de) Verfahren zur herstellung von neuen 3-halogencephalosporinverbindungen
AT345997B (de) Verfahren zur herstellung von neuen pyrimidinoaminomethylergolinderivaten
AT339310B (de) Verfahren zur herstellung von neuen chinolinderivaten
AT330160B (de) Verfahren zur herstellung von neuen biphenyl-derivaten
AT336606B (de) Verfahren zur herstellung von neuen tetrazol-5-yl-cumarinderivaten
AT338259B (de) Verfahren zur herstellung von neuen indolderivaten
ATA874574A (de) Verfahren zur herstellung von neuen 1-phthalazonderivaten
AT340406B (de) Verfahren zur herstellung von neuen isoindolderivaten
ATA471176A (de) Verfahren zur herstellung von neuen 1-phthalazonderivaten
AT336812B (de) Verfahren zur herstellung von neuen 21-fluor-19-norpregnadienverbindungen
ATA576475A (de) Verfahren zur herstellung von neuen 21-fluor-19-norpregnadienverbindungen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee